Anti-Drug Antibody (ADA)
Elfabrio ADA testing is available to patients at no cost who are prescribed Elfabrio treatment through a testing access program between Chiesi Global Rare Disease and Labcorp.
Labcorp proudly fosters partnerships dedicated to enhancing access and improving patient outcomes
nAbCyte™ Testing Program
The nAbCyte Anti-AAVRh74var HB-FE Assay for BEQVEZ™ (fidanacogene elaparvovec-dzkt) is a cell-based qualitative in vitro companion diagnostic device intended for the detection of neutralizing antibodies to the AAVRh74var capsid in serum specimens from adult patients previously diagnosed with moderate to severe hemophilia B to determine eligibility for treatment with the hemophilia B gene therapy, BEQVEZ.
Complementary Antibody Testing
Amicus is offering two antibody assay tests for Pombiliti (cipaglucosidase alfa-atga)
No-Charge KIT D816V Testing
Blueprint's biomarker testing program for systemic mastocytosis
FOLR1 IHC testing in ovarian cancer
Labcorp offers the ImmunoGen FR-ASSIST™ FOLR1 Immunohistochemistry (IHC) Sponsored Testing Program as a way to increase access to testing for patients with epithelial ovarian, fallopian tube or primary peritoneal cancer (EOC).